Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 8/20 | 0.57 |
| ▸ | FGF1 | P05230 | 1/20 | 0.44 |
| ▸ | OGA | O60502 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.40 |
| ▸ | PYGB | P11216 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13151561 | 1.00 | LGALS8 (0.57) | LGALS8FGF1OGAL3MBTL1GAA | |
| SCHEMBL10781121 | 1.00 | LGALS8 (0.57) | LGALS8FGF1OGAL3MBTL1GAA | |
| SCHEMBL15095565 | 1.00 | LGALS8 (0.57) | LGALS8FGF1OGAL3MBTL1GAA | |
| SCHEMBL13180919 | 1.00 | LGALS8 (0.57) | LGALS8FGF1OGAL3MBTL1GAA | |
| SCHEMBL14010636 | 1.00 | LGALS8 (0.57) | LGALS8FGF1OGAL3MBTL1GAA | |
| SCHEMBL10781125 | 1.00 | LGALS8 (0.57) | LGALS8FGF1OGAL3MBTL1GAA | |
| SCHEMBL23705114 | 0.94 | LGALS8 (0.51) | LGALS8FGF1L3MBTL1GAAMAPT | |
| SCHEMBL7147710 | 0.94 | LGALS8 (0.51) | LGALS8FGF1L3MBTL1GAAMAPT | |
| SCHEMBL14846432 | 0.94 | LGALS8 (0.55) | LGALS8FGF1OGAL3MBTL1GAA | |
| SCHEMBL20115303 | 0.94 | LGALS8 (0.55) | LGALS8FGF1OGAL3MBTL1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159922-A1 | MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF | IONIS PHARMACEUTICALS, INC. (US) | 2023-05-25 | — | — | US | disclosed |